文献速递复苏、休克与脓毒症重症综合管理与镇静镇痛

倾向性评分匹配分析估算疫苗接种对重症COVID-19患者的影响

Estimation of the effect of vaccination in critically ill COVID-19 patients, analysis using propensity score matching.
PubMed 文献 · Ann Intensive Care · 2024-02-12
一句话结论在重症COVID-19患者中,接种疫苗与ICU死亡率降低相关(倾向性评分匹配OR 0.83,95%CI 0.77–0.91)。

该研究纳入2020年6月15日至2021年12月31日期间需ICU入院的COVID-19患者,比较未接种与接种疫苗者的ICU死亡率。共667例(79.31%)未接种、174例(20.68%)接种;平均年龄57.11岁(SD 15.13),70.27%为男性;ICU死亡率为56.60%(95%CI 53.24–60%)。多因素logistic回归和倾向性评分匹配均显示接种疫苗者死亡风险更低:logistic回归校正OR 0.52(95%CI 0.29–0.94),倾向性评分匹配OR 0.83(95%CI 0.77–0.91)。作者认为该结果支持COVID-19疫苗接种是降低病死率的有效方法,不仅适用于一般人群,也适用于重症患者,具有重要公共卫生意义。

要点

  • 在需ICU入院的重症COVID-19患者中,接种疫苗与ICU死亡率降低相关:倾向性评分匹配OR 0.83(95%CI 0.77–0.91),logistic回归校正OR 0.52(95%CI 0.29–0.94)。
  • 研究共纳入841例患者,其中未接种667例(79.31%)、接种174例(20.68%),ICU死亡率为56.60%(95%CI 53.24–60%)。
  • 纳入时间为2020年6月15日至2021年12月31日,纳入标准为需ICU入院的未接种和接种COVID-19患者。
  • 主要结局为ICU死亡率,次要结局为ICU住院时间和机械通气持续时间。
  • 作者认为该研究支持COVID-19疫苗接种是降低病死率的有效方法,不仅适用于一般人群,也适用于重症患者。

适用人群与场景

  • 2020年6月15日至2021年12月31日期间需ICU入院的COVID-19患者,包括未接种和接种疫苗者。

研究设计与关键结果

  • 研究类型为采用多因素logistic回归和倾向性评分匹配的分析;共纳入841例患者,其中未接种667例(79.31%)、接种174例(20.68%);平均年龄57.11岁(SD 15.13),70.27%为男性;ICU死亡率为56.60%(95%CI 53.24–60%)。
  • 主要结局ICU死亡率:多因素logistic回归校正OR 0.52(95%CI 0.29–0.94),倾向性评分匹配OR 0.83(95%CI 0.77–0.91),均显示接种疫苗者死亡风险更低。
  • 次要结局为ICU住院时间和机械通气持续时间,原文未报告具体结果数值。

证据类型、等级与局限

  • 证据类型:基于医疗机构数据的观察性分析,采用多因素logistic回归和倾向性评分匹配。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 作者认为,该研究结果支持COVID-19疫苗接种是降低病死率的有效方法,不仅适用于一般人群,也适用于重症患者,具有重要公共卫生意义。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

BACKGROUND: Vaccination helped in reducing mortality and disease severity due to COVID-19. Some patients can develop breakthrough infections. The effect of vaccination in critically ill patients admitted with breakthrough infections is not well studied. We designed a study to estimate the effect of vaccination on ICU mortality in critically ill COVID-19 patients by using propensity score matching.

METHODS: We included patients from 15th June 2020 to 31st December 2021. Inclusion criteria were unvaccinated and vaccinated COVID-19 patients requiring intensive care unit (ICU) admission. The institutional ethics committee approval was obtained (institutional ethics committee, IEC 08/2023, Clinical trial registry, India CTRI/2023/01/049142). The primary outcome was ICU mortality. The secondary outcomes were the length of ICU stay and duration of mechanical ventilation. We used multivariable logistic regression (MLR) and propensity score matching (PSM) for the statistical analysis.

RESULTS: Total of 667 patients (79.31%) were unvaccinated and 174 (20.68%) vaccinated. The mean age was 57.11 [standard deviation (SD) 15.13], and 70.27% were males. The ICU mortality was 56.60% [95% confidence interval (CI) 53.24-60%]. The results of MLR and PSM method showed that vaccinated patients were less likely to be associated with mortality [adjusted odds ratio (AOR), 95% CI using logistic regression: 0.52 (0.29, 0.94), and by propensity score matching: 0.83 (0.77, 0.91)].

CONCLUSION: The findings of this study support COVID-19 vaccination as an effective method for reducing case fatality not only in the general population but also in critically ill patients, and it has important public health implications.

来源:Ann Intensive Care,查看原文。版权归原作者所有。

参考来源

  1. Havaldar AA, Selvam S. Estimation of the effect of vaccination in critically ill COVID-19 patients, analysis using propensity score matching. Ann Intensive Care. 2024. PMID: 38342803. doi:10.1186/s13613-024-01257-7

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。